Sitala Bio

Sitala Bio is dedicated to treating neurodegenerative and inflammatory diseases by blocking harmful inflammation

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

Sitala Bio is dedicated to treating neurodegenerative and inflammatory diseases by blocking harmful inflammation. The company aims to translate cutting-edge science into new therapies for conditions such as Parkinson’s and Alzheimer’s.

02Backed By1 investor

ALAdvent Life Sciences→

03Recent Activity

Is this your company? Claim your profile

FROM Advent Life Sciences

Co-led Sitala Bio's Series B financing in 2025.

INVESTMENT·adventls.com

Added recently

04Similar Companies

RP

Reata Pharmaceuticals

Biotech & Life Sciences

→

MB

Montis Biosciences

Biotech & Life Sciences

→

MT

MindImmune Therapeutics

Biotech & Life Sciences

→

T

TrueBinding

Biotech & Life Sciences

→

AP

Anacor Pharmaceuticals

Biotech & Life Sciences

→

05Startup DNA

8

signals

Sectors
Business Model
Technology